1. Home
  2. VYGR vs FRAF Comparison

VYGR vs FRAF Comparison

Compare VYGR & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.15

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Logo Franklin Financial Services Corporation

FRAF

Franklin Financial Services Corporation

HOLD

Current Price

$56.64

Market Cap

206.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
FRAF
Founded
2013
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
232.4M
206.3M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
FRAF
Price
$4.15
$56.64
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
468.2K
53.4K
Earning Date
11-10-2025
01-27-2026
Dividend Yield
N/A
2.35%
EPS Growth
N/A
9.43
EPS
N/A
3.50
Revenue
$31,316,000.00
$77,783,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$71.78
N/A
P/E Ratio
N/A
$16.03
Revenue Growth
N/A
8.75
52 Week Low
$2.65
$28.01
52 Week High
$6.47
$56.84

Technical Indicators

Market Signals
Indicator
VYGR
FRAF
Relative Strength Index (RSI) 45.25 76.49
Support Level $4.24 $55.61
Resistance Level $4.58 $56.84
Average True Range (ATR) 0.23 1.18
MACD 0.02 0.12
Stochastic Oscillator 48.52 84.33

Price Performance

Historical Comparison
VYGR
FRAF

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

Share on Social Networks: